首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Distinct cell death pathways triggered by the adenovirus early region 4 ORF 4 protein
Authors:Robert Amélie  Miron Marie-Joëlle  Champagne Claudia  Gingras Marie-Claude  Branton Philip E  Lavoie Josée N
Institution:1.Centre de recherche en cancérologie de l''Université Laval, L''Hôtel-Dieu de Québec, CHUQ, Québec G1R 2J6, Canada; 2.Department of Biochemistry, McGill University, Montreal, Québec H3G 1Y6, Canada; 3.the McGill Cancer Centre, McGill University, Montreal, Québec H3G 1Y6, Canada
Abstract:In transformed cells, induction of apoptosis by adenovirus type 2 (Ad2) early region 4 ORF 4 (E4orf4) correlates with accumulation of E4orf4 in the cell membrane-cytoskeleton fraction. However, E4orf4 is largely expressed in nuclear regions before the onset of apoptosis. To determine the relative contribution of nuclear E4orf4 versus membrane-associated E4orf4 to cell death signaling, we engineered green fluorescent fusion proteins to target E4orf4 to specific cell compartments. The targeting of Ad2 E4orf4 to cell membranes through a CAAX-box or a myristylation consensus signal sufficed to mimic the fast Src-dependent apoptotic program induced by wild-type E4orf4. In marked contrast, the nuclear targeting of E4orf4 abolished the early induction of extranuclear apoptosis. However, nuclear E4orf4 still induced a delayed cell death response independent of Src-like activity and of E4orf4 tyrosine phosphorylation. The zVAD.fmk-inhibitable caspases were dispensable for execution of both cell death programs. Nevertheless, both pathways led to caspase activation in some cell types through the mitochondrial pathway. Finally, our data support a critical role for calpains upstream in the death effector pathway triggered by the Src-mediated cytoplasmic death signal. We conclude that Ad2 E4orf4 induces two distinct cell death responses, whose relative contributions to cell killing may be determined by the genetic background.
Keywords:Ad2 E4orf4  apoptosis  Src kinases  caspase  calpastatin
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号